Rajiv Devanagondi1, Xi Zhang2, Zhen Xu3, Kimberly Ives4, Albert Levin5, Hitinder Gurm6, Gabe E Owens7. 1. Center for Pediatric and Congenital Heart Disease, Cleveland Clinic, 9500 Euclid Avenue, M4-37A, Cleveland, OH 44915.. Electronic address: rajiv.devanagondi@gmail.com. 2. Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan. 3. Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan.; Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, Michigan. 4. Department of Radiology, University of Michigan Medical School, Ann Arbor, Michigan. 5. Henry Ford Health System, Detroit, Michigan. 6. Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan Medical School, Ann Arbor, Michigan. 7. Michigan Congenital Heart Center, Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan.
Abstract
PURPOSE: To investigate the extent and consequences of histotripsy-induced hemolysis in vivo. MATERIALS AND METHODS: Porcine femoral venous blood was treated with histotripsy in 11 animals with systemic heparinization and 11 without heparin. Serum and hemodynamic measurements were obtained at 0, 2, 5, 10, 15, and 30 minutes and 48-72 hours after the procedure. Fisher exact test was used to determine differences in mortality between heparinized and nonheparinized groups. A linear mixed effects model was used to test for differences in blood analytes and hemodynamic variables over time. RESULTS: Of 11 animals in the nonheparinized group, 5 died during or immediately after histotripsy (45% nonheparin mortality vs 0% heparin mortality, P = .035). Serum hematocrit, free hemoglobin, lactate dehydrogenase (LDH), and right ventricular systolic pressure changed significantly (P < .001) over the treatment time. Serum hematocrit decreased slightly (from 32.5% ± 3.6% to 29.4% ± 4.2%), whereas increases were seen in free hemoglobin (from 6.2 mg/dL ± 4.6 to 348 mg/dL ± 100), LDH (from 365 U/L ± 67.8 ± to 722 U/L ± 84.7), and right ventricular systolic pressure (from 23.2 mm Hg ± 7.2 to 39.7 mm Hg ± 12.3). After 48-72 hours, hematocrit remained slightly decreased (P = .005), whereas LDH and free hemoglobin remained slightly increased compared with baseline (both P < .001). CONCLUSIONS: Intravascular histotripsy applied to free-flowing venous blood is safe with systemic heparinization, causing only transient hemodynamic and metabolic disturbances, supporting its use as a future noninvasive thrombolytic therapy modality.
PURPOSE: To investigate the extent and consequences of histotripsy-induced hemolysis in vivo. MATERIALS AND METHODS: Porcine femoral venous blood was treated with histotripsy in 11 animals with systemic heparinization and 11 without heparin. Serum and hemodynamic measurements were obtained at 0, 2, 5, 10, 15, and 30 minutes and 48-72 hours after the procedure. Fisher exact test was used to determine differences in mortality between heparinized and nonheparinized groups. A linear mixed effects model was used to test for differences in blood analytes and hemodynamic variables over time. RESULTS: Of 11 animals in the nonheparinized group, 5 died during or immediately after histotripsy (45% nonheparin mortality vs 0% heparin mortality, P = .035). Serum hematocrit, free hemoglobin, lactate dehydrogenase (LDH), and right ventricular systolic pressure changed significantly (P < .001) over the treatment time. Serum hematocrit decreased slightly (from 32.5% ± 3.6% to 29.4% ± 4.2%), whereas increases were seen in free hemoglobin (from 6.2 mg/dL ± 4.6 to 348 mg/dL ± 100), LDH (from 365 U/L ± 67.8 ± to 722 U/L ± 84.7), and right ventricular systolic pressure (from 23.2 mm Hg ± 7.2 to 39.7 mm Hg ± 12.3). After 48-72 hours, hematocrit remained slightly decreased (P = .005), whereas LDH and free hemoglobin remained slightly increased compared with baseline (both P < .001). CONCLUSIONS: Intravascular histotripsy applied to free-flowing venous blood is safe with systemic heparinization, causing only transient hemodynamic and metabolic disturbances, supporting its use as a future noninvasive thrombolytic therapy modality.
Authors: S L Poliachik; W L Chandler; P D Mourad; M R Bailey; S Bloch; R O Cleveland; P Kaczkowski; G Keilman; T Porter; L A Crum Journal: Ultrasound Med Biol Date: 1999-07 Impact factor: 2.998
Authors: Zhen Xu; Achiau Ludomirsky; Lucy Y Eun; Timothy L Hall; Binh C Tran; J Brian Fowlkes; Charles A Cain Journal: IEEE Trans Ultrason Ferroelectr Freq Control Date: 2004-06 Impact factor: 2.725
Authors: Weiguo Hu; Richard Jin; Jinyan Zhang; Tao You; Zhihai Peng; Xiaowen Ge; Roderick T Bronson; Jose A Halperin; Joseph Loscalzo; Xuebin Qin Journal: Blood Date: 2010-05-28 Impact factor: 22.113
Authors: P C Kouretas; R L Hannan; N K Kapur; R Hendrickson; E M Redmond; A K Myers; Y D Kim; P A Cahill; J V Sitzmann Journal: J Mol Cell Cardiol Date: 1998-12 Impact factor: 5.000
Authors: Elvira V Lang; Anne M Kulis; Mario Villani; William Barnhart; Richard Balano; Robert Cohen Journal: J Vasc Interv Radiol Date: 2008-06-02 Impact factor: 3.464
Authors: Mark T Gladwin; Vandana Sachdev; Maria L Jison; Yukitaka Shizukuda; Jonathan F Plehn; Karin Minter; Bernice Brown; Wynona A Coles; James S Nichols; Inez Ernst; Lori A Hunter; William C Blackwelder; Alan N Schechter; Griffin P Rodgers; Oswaldo Castro; Frederick P Ognibene Journal: N Engl J Med Date: 2004-02-26 Impact factor: 91.245
Authors: Douglas L Miller; Xiaofang Lu; Chunyan Dou; Yiying I Zhu; Rachael Fuller; Kristina Fields; Mario L Fabiilli; Gabe E Owens; David Gordon; Oliver D Kripfgans Journal: Ultrasound Med Biol Date: 2018-04-19 Impact factor: 2.998
Authors: Xi Zhang; Jonathan J Macoskey; Kimberly Ives; Gabe E Owens; Hitinder S Gurm; Jiaqi Shi; Matthew Pizzuto; Charles A Cain; Zhen Xu Journal: Ultrasound Med Biol Date: 2017-04-28 Impact factor: 2.998
Authors: Tyler Gerhardson; Jonathan R Sukovich; Aditya S Pandey; Timothy L Hall; Charles A Cain; Zhen Xu Journal: IEEE Trans Ultrason Ferroelectr Freq Control Date: 2017-08-31 Impact factor: 2.725
Authors: Xi Zhang; Lifang Jin; Eli Vlaisavljevich; Gabe E Owens; Hitinder S Gurm; Charles A Cain; Zhen Xu Journal: IEEE Trans Ultrason Ferroelectr Freq Control Date: 2015-12 Impact factor: 2.725
Authors: Aiwei Shi; Zhen Xu; Jonathan Lundt; Hedieh A Tamaddoni; Tejaswi Worlikar; Timothy L Hall Journal: IEEE Trans Ultrason Ferroelectr Freq Control Date: 2018-07-23 Impact factor: 2.725